In-Silico Design & Synthesis of MurB Inhibitors as Antibacterial Agent | Designing & Synthesis of Novel Target-MurB Inhibitors as Antibacterial Agents

Sanjay Patel (u. a.)

ISBN 10: 3843371091 / ISBN 13: 9783843371094

Published by LAP LAMBERT Academic Publishing, 2012

About this Item

In-Silico Design & Synthesis of MurB Inhibitors as Antibacterial Agent | Designing & Synthesis of Novel Target-MurB Inhibitors as Antibacterial Agents | Sanjay Patel (u. a.) | Taschenbuch | 148 S. | Englisch | 2012 | LAP LAMBERT Academic Publishing | EAN 9783843371094 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Seller Inventory # 106485172

Bibliographic Details

• Title: In-Silico Design & Synthesis of MurB Inhibitors as Antibacterial Agent | Designing & Synthesis of Novel Target-MurB Inhibitors as Antibacterial Agents
• Publisher: LAP LAMBERT Academic Publishing
• Publication Date: 2012
• Language: English
• ISBN 10: 3843371091
• ISBN 13: 9783843371094
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 10D millimeters 220 millimeters width by 150 millimeters height by 10 millimeters depth
• Weight: 238 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Heterobicyclic oxazolo pyrimidinone are important class of compounds. They may become promising candidates for exploiting more useful therapeutically active molecules. The compounds having oxazolo pyrimidinone moiety are associated with interesting wide spectrum biological activities, such as antibacterial, kinase inhibition, adenosine receptor antagonism, tumour growth inhibition and some show to inhibit the ability of ricin to inactivate the ribosomes etc. The intermediate azlactones are also useful precursors for the synthesis of amino acids, peptides, heterocycles, biosensors and antitumor or antimicrobial compounds. In the present study, it was proposed to synthesize lead molecules of oxazolo pyrimidinone skeleton, apt for binding to the target enzyme, bacterial MurB based on the rational approach and to study their docking simulations using ArgusLab 4.0.1 and AutoDock 4.2 softwares. The synthesized test compounds were then characterized by TLC, melting point determination, UV, IR, 1H-NMR and mass spectral studies and tested for their antibacterial activity and compare with the standard drug.

About the Author

I have completed M.Pharm (Pharm. Chemistry) from Gujarat Technological University, Gujarat (India). Currently working as a Research Associate Scientist in Piramal Discovery Solutions. I have expertise in Drug designing & also have sound knowledge of Chemistry. My research work is dedicated to my PARENTS.